Julien Alberici

Chief Executive Officer at

Mathym SAS

Finance

Commercial Services

Process Industries

Profile

Julien Alberici is the founder.
Founded Mathym SAS in 2013 as Chief Executive Officer.
Current job at Octalfa SAS since 2013 as CEO.
Current job at ORPHELIA Pharma SAS as Director.
Former job at Baikowski SA as Director-Business Development.

Julien Alberici active positions

Companies	Position	Start
Octalfa SAS Octalfa SAS Investment ManagersFinance Octalfa is a hands-on investor who plays an active role in their portfolio companies and seeks board representation. The firm focuses on early-stage businesses including seed-stage projects in the life sciences sectors, and may also co-invest in later-stage companies. Octalfa invests from their own balance sheet, in the EUR 500 thousand to 1.5 million range, as a one-time investor or over several financing rounds.	Chief Administrative Officer	2012-12-31
Mathym SAS Mathym SAS Miscellaneous Commercial ServicesCommercial Services Manufacutures and developps innovative colloïdal solutions.	Chief Executive Officer	2013-08-31
ORPHELIA Pharma SAS ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology Specializes on biopharmaceutical products improving the health and well being of severely disabled children	Director/Board Member	-

All active positions of Julien Alberici

Former positions of Julien Alberici

Companies	Position	End
BAIKOWSKI	Corporate Officer/Principal	-

See the detail of Julien Alberici's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Julien Alberici's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Octalfa SAS Octalfa SAS Investment ManagersFinance Octalfa is a hands-on investor who plays an active role in their portfolio companies and seeks board representation. The firm focuses on early-stage businesses including seed-stage projects in the life sciences sectors, and may also co-invest in later-stage companies. Octalfa invests from their own balance sheet, in the EUR 500 thousand to 1.5 million range, as a one-time investor or over several financing rounds.	Finance
Mathym SAS Mathym SAS Miscellaneous Commercial ServicesCommercial Services Manufacutures and developps innovative colloïdal solutions.	Commercial Services
Baikowski SA Baikowski SA Chemicals: SpecialtyProcess Industries Produces and supplies alumina powders, phosphors & formulations	Process Industries
ORPHELIA Pharma SAS ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology Specializes on biopharmaceutical products improving the health and well being of severely disabled children	Health Technology